CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5 enrolled
Drug / intervention
Proton Radiation Therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01557790
NCT01557790N/ACompleted

A Phase II Study of Adjuvant Proton Radiation Therapy for the Treatment of Stage I, IIA and IIB Seminoma

Abramson Cancer Center at Penn Medicine·interventional·Posted Mar 20, 2012·Updated Apr 13, 2020

In Brief

A clinical study evaluating Proton Radiation Therapy for Stage I, IIA and IIB Seminoma. Completed, enrolled 5 participants across 2 sites.

Detailed Summary

Phase II study using Proton radiation therapy to treat males, aged 18 years or older, with Stage I, IIA and IIB Seminoma. This research study will be done in conjunction with the Robert H. Burr Proton Therapy Center at the Mass. General Hospital and the Department of Defense. In the feasibility portion of the study patients will be evaluated to determine acute toxicity. If the study is deemed feasible the principal investigator (PI) hopes that proton RT will reduce the lethargy rate as compared to photon radiation therapy (RT).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 20, 2012
Enrollment StartMar 1, 2012
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 14.3 years ago

Interventions

Proton Radiation Therapyradiation